Purchase Order 75N95021P00620
Award Date 9/20/21
Potential Completion Date 11/11/23
Potential Value $136K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Brighton, MA 02135, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award from the Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development (NICHD) was made to Nanoview Biosciences, Inc., doing business as Nanoview Diagnostics, a for-profit organization. The contract, valued at $166,762.45, is for the provision of an ExoView R200 Imaging Platform and related upgrades. This contract was awarded on a firm fixed-price basis and did not utilize any set-aside designations....
- The U.S. Food and Drug Administration (FDA) awarded a $140,460.04 firm fixed-price purchase order contract to Nanoview Biosciences, Inc., a small business concern. The contract is for the provision of the NANOVIEW BIOSCIENCES EXOVIEW R100 system, a specialized imaging equipment used for testing services. This award is a small business set-aside contract and represents the fourth federal contract received by Nanoview Biosciences from the Department of Health and Human Services, including the...
- This is a $42,000.00 firm-fixed-price purchase order awarded by the National Institute on Aging, a civilian agency, to Nanometrix LTD, a for-profit organization based in the United Kingdom. The contract is for single extracellular vesicle (EV) analysis services, including EV sample preparation, imaging, size and morphological analysis, quality assurance, and molecular profile assessment on 30 plasma samples provided by the government. This non-competitive commercial item acquisition is being...
- The National Institute on Aging awarded a purchase order to Vizgen Inc. on August 28, 2025, with a ceiling value of $23,665 for in vitro diagnostic substances, reagents, test kits, and MERSCOPE equipment and reagents. This firm fixed-price contract, which carries an ultimate completion date of November 27, 2025, supports the agency's research initiatives through the procurement of specialized spatial genomics technology. The award was made without a set-aside designation and is being performed...
- This federal contract award, valued at $249,990.00, was issued by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH) under the Department of Health and Human Services. The prime contractor is 10X Genomics, Inc., a life sciences technology company that specializes in products and services for single-cell and spatial analysis applications. The award is for the delivery of six (6) Chromium Next GEM Single Cell Multiome ATAC and Gene Expression Reagent...
- This federal contract award was made by the National Institute on Aging (NIA), part of the U.S. Department of Health and Human Services (HHS), to 10X Genomics, Inc. The $17,056.50 firm fixed price delivery order (Contract #75N95D24F40007) provides 10X Genomics' Xenium Standalone Custom 301 to 480 Gene Panel for 4 reactions. This award is part of a larger indefinite delivery contract (Contract #75N95024D00029) with a $750,000 ceiling value that the NIA has with 10X Genomics to supply optimization...
- This is a firm fixed-price delivery order awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, to 10X Genomics, Inc., a for-profit manufacturer of life sciences technology. The contract is valued at $44,969.00 and runs through July 28, 2025. The contract provides for the delivery of biological and reagent materials, specifically reagent and gene expression kits, to support the NIA's biomedical research efforts. This delivery...
- This federal contract award is for the provision of in-vitro diagnostic substance manufacturing, specifically the GEM-X Universal Gene Expression and GEM-X Single Cell Chip Kits, to the National Institute on Aging, a civilian agency. The prime contractor is 10X Genomics, Inc., a biotechnology company specializing in advanced genomic analysis platforms, reagents, instruments, and bioinformatics software. The contract has a ceiling value of $246,534.60 and an ultimate completion date of December...
- The National Institute on Aging (NIA), a civilian agency within the Department of Health and Human Services, awarded a firm fixed price delivery order contract worth $22,484.00 to 10X Genomics, Inc. for the provision of Visium Spatial Gene Expression Starter Kits. This order is part of a larger indefinite delivery contract valued at up to $750,000 that 10X Genomics holds with the National Institute of Neurological Disorders and Stroke to support research into neurological diseases and disorders....
- This federal contract award was made by the National Institute on Aging (NIA), a civilian agency under the Department of Health and Human Services (HHS), to the prime contractor 10X Genomics, Inc. The $14,446.50 fixed-price delivery order contract is for the provision of LABORATORY SUPPLIES - GEM-X CHROMIUM CELL KITS. 10X Genomics, a for-profit manufacturer of life sciences products and services, will deliver these single-cell analysis kits to support the NIA's biomedical research efforts,...